Geographic and age variations in mutational processes in colorectal cancer

. 2025 Jul ; 643 (8070) : 230-240. [epub] 20250423

Jazyk angličtina Země Velká Británie, Anglie Médium print-electronic

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/pmid40267983

Grantová podpora
R01 ES032547 NIEHS NIH HHS - United States
U01 CA167551 NCI NIH HHS - United States
U01 CA290479 NCI NIH HHS - United States
Wellcome Trust - United Kingdom
R01 CA269919 NCI NIH HHS - United States
001 World Health Organization - International

Odkazy

PubMed 40267983
PubMed Central PMC12221974
DOI 10.1038/s41586-025-09025-8
PII: 10.1038/s41586-025-09025-8
Knihovny.cz E-zdroje

Incidence rates of colorectal cancer vary geographically and have changed over time1. Notably, in the past two decades, the incidence of early-onset colorectal cancer, which affects individuals below 50 years of age, has doubled in many countries2-5. The reasons for this increase are unknown. Here we investigate whether mutational processes contribute to geographic and age-related differences by examining 981 colorectal cancer genomes from 11 countries. No major differences were found in microsatellite-unstable cancers, but variations in mutation burden and signatures were observed in the 802 microsatellite-stable cases. Multiple signatures, most with unknown aetiologies, exhibited varying prevalence in Argentina, Brazil, Colombia, Russia and Thailand, indicating geographically diverse levels of mutagenic exposure. Signatures SBS88 and ID18, caused by the bacteria-produced mutagen colibactin6,7, had higher mutation loads in countries with higher colorectal cancer incidence rates. SBS88 and ID18 were also enriched in early-onset colorectal cancers, being 3.3 times more common in individuals who were diagnosed before 40 years of age than in those over 70 years of age, and were imprinted early during colorectal cancer development. Colibactin exposure was further linked to APC driver mutations, with ID18 being responsible for about 25% of APC driver indels in colibactin-positive cases. This study reveals geographic and age-related variations in colorectal cancer mutational processes, and suggests that mutagenic exposure to colibactin-producing bacteria in early life may contribute to the increasing incidence of early-onset colorectal cancer.

2nd Faculty of Medicine Charles University and Motol University Hospital Prague Czech Republic

Biomedical Sciences Graduate Program University of California San Diego La Jolla CA USA

Cancer Ageing and Somatic Mutation Wellcome Sanger Institute Cambridge UK

Centre for Biodiversity Genomics University of Guelph Guelph Ontario Canada

Clinic for Digestive Surgery 1st Surgical Clinic University Clinical Centre of Serbia Belgrade Serbia

Clinical Center ISCARE Prague Czech Republic

Clinical Epidemiology N N Blokhin National Medical Research Centre of Oncology Moscow Russia

Colon Cancer Reference Center A C Camargo Cancer Center Sao Paulo Brazil

Department of Bioengineering University of California San Diego La Jolla CA USA

Department of Biomedical Sciences and Biomedical Engineering Faculty of Medicine Prince of Songkla University Hat Yai Thailand

Department of Cellular and Molecular Medicine University of California San Diego La Jolla CA USA

Department of Colorectal Oncology Surgery Barretos Cancer Hospital Barretos Brazil

Department of Endoscopy Barretos Cancer Hospital Barretos Brazil

Department of Environmental Epidemiology Nofer Institute of Occupational Medicine Łódź Poland

Department of Epidemiology A C Camargo Cancer Center Sao Paulo Brazil

Department of Genetics Universidade Federal do Rio Grande do Sul Porto Alegre Brazil

Department of Health Informatics Graduate School of Informatics Middle East Technical University Ankara Turkey

Department of Internal Medicine Faculty of Medicine Chiang Mai University Chiang Mai Thailand

Department of Oncology 2nd Faculty of Medicine Charles University and University Hospital Motol Prague Czech Republic

Department of Pathology Anatomic Pathology Hospital de Clínicas de Porto Alegre Porto Alegre Brazil

Department of Pathology Barretos Cancer Hospital Barretos Brazil

Department of Pathology The Maria Sklodowska Cure National Research Institute of Oncology Warsaw Poland

Department of Pathology University Clinical Centre of Serbia Belgrade Serbia

Department of Surgery Division of Colorectal Surgery Hospital de Clínicas de Porto Alegre Porto Alegre Brazil

Department of Surgery Faculty of Medicine Prince of Songkla University Hat Yai Thailand

Digestive Oncology Research Center Digestive Disease Research Institute Tehran University of Medical Sciences Tehran Iran

Digital Genomics Group Structural Biology Program Spanish National Cancer Research Center Madrid Spain

Division of Cancer Epidemiology and Genetics National Cancer Institute Bethesda MD USA

Division of Cancer Genomics National Cancer Center Research Institute Chuo ku Japan

Evidence Synthesis and Classification Branch International Agency for Research on Cancer Lyon France

Genomic Epidemiology Branch International Agency for Research on Cancer Lyon France

Golestan Research Center of Gastroenterology and Hepatology Golestan University of Medical Sciences Gorgan Iran

Institute of Animal Physiology and Genetics Czech Academy of Science Libechov Czech Republic

Institute of Hygiene and Epidemiology 1st Faculty of Medicine Charles University Prague Czech Republic

Instituto de Medicina Traslacional e Ingeniería Biomédica Buenos Aires Argentina

International Organization for Cancer Prevention and Research Belgrade Serbia

Laboratory of Molecular Medicine The Institute of Medical Science The University of Tokyo Minato ku Japan

Life and Health Sciences Research Institute School of Medicine Minho University Braga Portugal

Lunenfeld Tanenbaum Research Institute Sinai Health System Toronto Ontario Canada

Medical Genetics Service Hospital de Clínicas de Porto Alegre Porto Alegre Brazil

Molecular Oncology Research Center Barretos Cancer Hospital Barretos Brazil

Moores Cancer Center University of California San Diego La Jolla CA USA

National Cancer Institute Bangkok Thailand

Oncological Pathology Group Terry Fox National Tumor Bank National Cancer Institute Bogotá Colombia

Ontario Tumour Bank Ontario Institute for Cancer Research Toronto Ontario Canada

Parasites and Microbes Wellcome Sanger Institute Cambridge UK

Sanford Stem Cell Institute University of California San Diego La Jolla CA USA

Surgery Department 2nd Faculty of Medicine Charles University and Central Military Hospital Prague Czech Republic

The Maria Sklodowska Cure National Research Institute of Oncology Warsaw Poland

Translational Medicine Research Center Faculty of Medicine Prince of Songkla University Hat Yai Thailand

Před aktualizací

PubMed

Zobrazit více v PubMed

Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. PubMed

Siegel, R. L., Jemal, A. & Ward, E. M. Increase in incidence of colorectal cancer among young men and women in the United States. PubMed

Vuik, F. E. et al. Increasing incidence of colorectal cancer in young adults in Europe over the last 25 years. PubMed PMC

Siegel, R. L. et al. Global patterns and trends in colorectal cancer incidence in young adults. PubMed

Patel, S. G., Karlitz, J. J., Yen, T., Lieu, C. H. & Boland, C. R. The rising tide of early-onset colorectal cancer: a comprehensive review of epidemiology, clinical features, biology, risk factors, prevention, and early detection. PubMed

Lee-Six, H. et al. The landscape of somatic mutation in normal colorectal epithelial cells. PubMed

Pleguezuelos-Manzano, C. et al. Mutational signature in colorectal cancer caused by genotoxic PubMed PMC

Brennan, P. & Davey-Smith, G. Identifying novel causes of cancers to enhance cancer prevention: new strategies are needed. PubMed PMC

Ames, B. N., Durston, W. E., Yamasaki, E. & Lee, F. D. Carcinogens are mutagens: a simple test system combining liver homogenates for activation and bacteria for detection. PubMed PMC

Kucab, J. E. et al. A compendium of mutational signatures of environmental agents. PubMed PMC

Moody, S. et al. Mutational signatures in esophageal squamous cell carcinoma from eight countries with varying incidence. PubMed

Zhang, T. et al. Genomic and evolutionary classification of lung cancer in never smokers. PubMed PMC

Senkin, S. et al. Geographic variation of mutagenic exposures in kidney cancer genomes. PubMed PMC

Perdomo, S. et al. The Mutographs biorepository: A unique genomic resource to study cancer around the world. PubMed PMC

Torrens, L. et al. The complexity of tobacco smoke-induced mutagenesis in head and neck cancer. PubMed PMC

Stigliano, V., Sanchez-Mete, L., Martayan, A. & Anti, M. Early-onset colorectal cancer: a sporadic or inherited disease? PubMed PMC

Spaander, M. C. W. et al. Young-onset colorectal cancer. PubMed PMC

You, Y. N., Xing, Y., Feig, B. W., Chang, G. J. & Cormier, J. N. Young-onset colorectal cancer: is it time to pay attention? PubMed

Venugopal, A. & Carethers, J. M. Epidemiology and biology of early onset colorectal cancer. PubMed PMC

The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. PubMed PMC

Alexandrov, L. B. et al. The repertoire of mutational signatures in human cancer. PubMed PMC

Degasperi, A. et al. Substitution mutational signatures in whole-genome-sequenced cancers in the UK population. PubMed PMC

Cornish, A. J. et al. The genomic landscape of 2,023 colorectal cancers. PubMed PMC

Priestley, P. et al. Pan-cancer whole-genome analyses of metastatic solid tumours. PubMed PMC

Mendelaar, P. A. J. et al. Whole genome sequencing of metastatic colorectal cancer reveals prior treatment effects and specific metastasis features. PubMed PMC

Martinez-Jimenez, F. et al. Pan-cancer whole-genome comparison of primary and metastatic solid tumours. PubMed PMC

Rosendahl Huber, A. et al. Improved detection of colibactin-induced mutations by genotoxic PubMed

Nunes, L. et al. Prognostic genome and transcriptome signatures in colorectal cancers. PubMed PMC

Díaz-Gay, M. & Alexandrov, L. B. in PubMed

Helleday, T., Eshtad, S. & Nik-Zainal, S. Mechanisms underlying mutational signatures in human cancers. PubMed PMC

Pich, O. et al. The mutational footprints of cancer therapies. PubMed PMC

Nik-Zainal, S. et al. Mutational processes molding the genomes of 21 breast cancers. PubMed PMC

Alexandrov, L. B. et al. Signatures of mutational processes in human cancer. PubMed PMC

Islam, S. M. A. et al. Uncovering novel mutational signatures by de novo extraction with SigProfilerExtractor. PubMed PMC

Alexandrov, L. B. et al. Clock-like mutational processes in human somatic cells. PubMed PMC

Gerstung, M. et al. The evolutionary history of 2,658 cancers. PubMed PMC

Dentro, S. C. et al. Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes. PubMed PMC

Chen, B. et al. Contribution of PubMed PMC

Martinez-Jimenez, F. et al. A compendium of mutational cancer driver genes. PubMed

Kim, J. E. et al. High prevalence of PubMed PMC

Díaz-Gay, M. et al. Assigning mutational signatures to individual samples and individual somatic mutations with SigProfilerAssignment. PubMed PMC

Terlouw, D. et al. Recurrent APC splice variant c.835-8A>G in patients with unexplained colorectal polyposis fulfilling the colibactin mutational signature. PubMed

Fearon, E. R. & Vogelstein, B. A genetic model for colorectal tumorigenesis. PubMed

Carethers, J. M. & Jung, B. H. Genetics and genetic biomarkers in sporadic colorectal cancer. PubMed PMC

Perdomo, S. Mutational signatures in five cancer types across five continents. Standard operating procedures (SOPs).

Harris, P. A. et al. Research electronic data capture (REDCap)–a metadata-driven methodology and workflow process for providing translational research informatics support. PubMed PMC

Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows-Wheeler transform. PubMed PMC

Whalley, J. P. et al. Framework for quality assessment of whole genome cancer sequences. PubMed PMC

Bergmann, E. A., Chen, B. J., Arora, K., Vacic, V. & Zody, M. C. Conpair: concordance and contamination estimator for matched tumor-normal pairs. PubMed PMC

Kim, S. et al. Strelka2: fast and accurate calling of germline and somatic variants. PubMed

Wang, K., Li, M. & Hakonarson, H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. PubMed PMC

Van Loo, P. et al. Allele-specific copy number analysis of tumors. PubMed PMC

Nik-Zainal, S. et al. The life history of 21 breast cancers. PubMed PMC

Jones, D. et al. cgpCaVEManWrapper: simple execution of CaVEMan in order to detect somatic single nucleotide variants in NGS data. PubMed PMC

Raine, K. M. et al. cgpPindel: identifying somatically acquired insertion and deletion events from paired end sequencing. PubMed PMC

Chen, X. et al. Manta: rapid detection of structural variants and indels for germline and cancer sequencing applications. PubMed

Bergstrom, E. N. et al. SigProfilerMatrixGenerator: a tool for visualizing and exploring patterns of small mutational events. PubMed PMC

Khandekar, A. et al. Visualizing and exploring patterns of large mutational events with SigProfilerMatrixGenerator. PubMed PMC

Gilson, P. et al. Evaluation of 3 molecular-based assays for microsatellite instability detection in formalin-fixed tissues of patients with endometrial and colorectal cancers. PubMed PMC

Liu, M., Wu, Y., Jiang, N., Boot, A. & Rozen, S. G. mSigHdp: hierarchical Dirichlet process mixture modeling for mutational signature discovery. PubMed PMC

Alexandrov, L. B., Nik-Zainal, S., Wedge, D. C., Campbell, P. J. & Stratton, M. R. Deciphering signatures of mutational processes operative in human cancer. PubMed PMC

Steele, C. D. et al. Signatures of copy number alterations in human cancer. PubMed PMC

Everall, A. et al. Comprehensive repertoire of the chromosomal alteration and mutational signatures across 16 cancer types from 10,983 cancer patients. Preprint at

Sondka, Z. et al. COSMIC: a curated database of somatic variants and clinical data for cancer. PubMed PMC

Senkin, S. MSA: reproducible mutational signature attribution with confidence based on simulations. PubMed PMC

Martincorena, I. et al. Universal patterns of selection in cancer and somatic tissues. PubMed PMC

Sondka, Z. et al. The COSMIC Cancer Gene Census: describing genetic dysfunction across all human cancers. PubMed PMC

Chakravarty, D. et al. OncoKB: a precision oncology knowledge base. PubMed PMC

Bailey, M. H. et al. Comprehensive characterization of cancer driver genes and mutations. PubMed PMC

Muiños, F., Martinez-Jimenez, F., Pich, O., Gonzalez-Perez, A. & Lopez-Bigas, N. In silico saturation mutagenesis of cancer genes. PubMed

Cheng, J. et al. Accurate proteome-wide missense variant effect prediction with AlphaMissense. PubMed

Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate—a practical and powerful approach to multiple testing.

Goncearenco, A. et al. Exploring background mutational processes to decipher cancer genetic heterogeneity. PubMed PMC

Langmead, B. & Salzberg, S. L. Fast gapped-read alignment with Bowtie 2. PubMed PMC

Chen, S., Zhou, Y., Chen, Y. & Gu, J. fastp: an ultra-fast all-in-one FASTQ preprocessor. PubMed PMC

Liao, W. W. et al. A draft human pangenome reference. PubMed PMC

Gu, Z., Gu, L., Eils, R., Schlesner, M. & Brors, B. circlize Implements and enhances circular visualization in R. PubMed

Mansournia, M. A., Geroldinger, A., Greenland, S. & Heinze, G. Separation in logistic regression: causes, consequences, and control. PubMed

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...